Published in Pol Tyg Lek on March 21, 1966
STUDIES ON THE MODE OF ACTION OF IRRADIATED ERGOSTEROL: II. Its Effect on the Calcium and Phosphorus Metabolism of Individuals with Calcium Deficiency Diseases. J Clin Invest (1932) 3.59
STUDIES ON THE MODE OF ACTION OF IRRADIATED ERGOSTEROL: I. Its effect on the Calcium, Phosphorus and Nitrogen Metabolism of Normal Individuals. J Clin Invest (1932) 2.16
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
Requirement of Bmp8b for the generation of primordial germ cells in the mouse. Mol Endocrinol (2000) 1.98
Diabetic nephropathy. An update. Arch Intern Med (1990) 1.61
LIVER FUNCTION TESTS IN CHRONIC RELAPSING VIVAX MALARIA. J Clin Invest (1945) 1.60
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
LOCAL IMMUNIZATION OF RABBITS TO CUTANEOUS INFECTION WITH STAPHYLOCOCCUS AUREUS. J Exp Med (1925) 1.34
STUDIES ON THE MODE OF ACTION OF IRRADIATED ERGOSTEROL: IV. in Hypoparathyroidism. J Clin Invest (1932) 1.18
Oral hypoglycaemic agents. An update. Drugs (1984) 1.18
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res (1989) 1.09
COMPLEMENT FIXATION IN HUMAN MALARIA USING AN ANTIGEN PREPARED FROM THE CHICKEN PARASITE PLASMODIUM GALLINACEUM. J Clin Invest (1945) 1.06
Asymptomatic bacteriuria in diabetes mellitus. N Engl J Med (1967) 1.05
Elevated serum human growth hormone and decreased serum insulin in prediabetic males after intravenous tolbutamide and glucose. J Clin Invest (1968) 1.04
STUDIES ON THE MODE OF ACTION OF IRRADIATED ERGOSTEROL: III. The Effect of Irradiated Ergosterol Administration on the Formation of Bone Trabeculae. J Clin Invest (1932) 1.04
Clinical and chemical diabetes in offspring of diabetic couples. N Engl J Med (1969) 1.03
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci U S A (1988) 1.00
Diminished serum insulin response to glucose in genetic prediabetic males with normal glucose tolerance. Diabetes (1968) 1.00
Glomerular lesions in a strain of genetically diabetic mice. Proc Soc Exp Biol Med (1968) 0.96
Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes (1990) 0.96
Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia (1981) 0.95
Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis. Arterioscler Thromb (1991) 0.94
Hereditary diabetes in the KK mouse: an overview. Adv Exp Med Biol (1988) 0.93
Twenty-five to forty-five years of diabetes with and without vascular complications. Diabetologia (1970) 0.91
Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. J Lipid Res (1988) 0.90
Diet therapy of diabetes mellitus. Med Clin North Am (1970) 0.89
Assessment of change in dynamic psychotherapy. J Psychother Pract Res (2000) 0.86
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen. Int J Clin Pharmacol Biopharm (1979) 0.85
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
Studies of vascular and other lesions in KK mice. Diabetologia (1970) 0.83
Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia (1995) 0.83
Radioimmunoassay of insulin, with use of an immunosorbent. Clin Chem (1974) 0.83
Charles Herbert Best 1899--1978. Diabetologia (1978) 0.83
Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. Biochim Biophys Acta (1989) 0.82
Retinopathy in mild diabetes of long duration. Arch Ophthalmol (1969) 0.82
Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic haemochromatosis. Eur J Clin Invest (1973) 0.81
Liver glycerokinase deficiency in man with hyperglycerolaemia and hypertriglyceridaemia. Eur J Clin Invest (1984) 0.81
HDL lipids in close relatives of coronary heart disease patients. Environmental and genetic influences. Atherosclerosis (1979) 0.81
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications. Biochim Biophys Acta (1991) 0.81
Insulin--clinical aspects: the first fifty years. Diabetes (1972) 0.81
HDL particle associated proteins in plasma and cerebrospinal fluid: identification and partial sequencing. Appl Theor Electrophor (1988) 0.81
Morphometric analysis on myocardial injury related to the use of high volume potassium cardioplegic solution during ischemic arrest. Pathol Res Pract (1992) 0.80
Diabetic microangiopathy in KK mice. VI. Effect of glycemic control on renal glycoprotein metabolism and established glomerulosclerosis. Exp Mol Pathol (1990) 0.80
Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. Atherosclerosis (1990) 0.80
Metabolic effects of dietary fiber from dehulled soybeans in humans. Am J Clin Nutr (1983) 0.80
The natural history of diabetes. Horm Metab Res (1974) 0.80
[Apoprotein E (apo E) phenotype and serum lipids in diabetics]. Schweiz Med Wochenschr (1987) 0.79
Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents? Drugs (1971) 0.79
Drug-induced reversal of early diabetic microangiopathy. N Engl J Med (1983) 0.79
Should oral amiodarone be used for sustained ventricular tachycardia in patients requiring open-heart surgery? Can J Surg (1983) 0.79
Abnormalities at the stage of chemical asymptomatic diabetes. Metabolism (1973) 0.79
Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms. Clin Chim Acta (1994) 0.78
The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 0.78
[Disorders in carbohydrate metabolism in the acute period of myocardial infarction. I. Evaluation of insulin-like activity of serum and cellular uptake of glucose]. Pol Arch Med Wewn (1969) 0.78
Muscle capillary basement membrane width in genetic prediabetes. J Clin Endocrinol Metab (1979) 0.78
Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care (1995) 0.78
Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII. J Lipid Res (1994) 0.78
Offspring of two diabetic parents: differential serum insulin responses to intravenous glucose and tolbutamide. J Clin Endocrinol Metab (1969) 0.78
High density lipoprotein cholesterol in male relatives of patients with coronary heart disease. Atherosclerosis (1979) 0.78
Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. Atherosclerosis (1986) 0.77
Acquired (secondary) forms of hypertriglyceridemia. Am J Cardiol (1991) 0.77
HDL and coronary heart disease: a familial trend. Adv Exp Med Biol (1987) 0.77
Effect of genetic diabetes on kidney glucosyltransferase. Horm Metab Res (1974) 0.77
Adrenergic responses to sustained handgrip in patients with juvenile-onset-type diabetes mellitus. Clin Sci Mol Med (1975) 0.77
Diagnosis of early asymptomatic diabetes. N Y State J Med (1966) 0.77
Underexpression of the apolipoprotein E4 isoform in an Italian population. Arterioscler Thromb (1993) 0.77
Factors influencing the low density lipoprotein profile in type 2 diabetic patients. Diabet Med (1995) 0.77
Prolonged fasting in mice: a more sensitive approach to genetic diabetes. Horm Res (1975) 0.76
Decreased HDL cholesterol in prepubertal and pubertal children of CHD patients. Atherosclerosis (1980) 0.76
HDL cholesterol levels in patients with myocardial infarction and their families. Atherosclerosis (1986) 0.76
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
Elevated kidney glucosyltransferase activity in genetic prediabetic mice. Experientia (1976) 0.76
Nine years' experience with tolbutamide in the treatment of diabetes. Metabolism (1966) 0.76
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am J Ophthalmol (1994) 0.75
Relation of Control of Diabetes to Vascular Degenerative Lesions in Young Diabetics. Trans Am Clin Climatol Assoc (1950) 0.75
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency. Eur J Pediatr (1997) 0.75
Corneal calcification in spontaneously daibetic mice. Invest Ophthalmol (1970) 0.75
Effect of several hormones on the tolerance to glucose in the non diabetic stage of KK mice. J Exp Zool (1969) 0.75
Critical variables in the radioimmunological technique for measuring immunoreactive insulin with use of immunosorbents. Clin Chem (1973) 0.75
The Banting Memorial Lecture 1967. Angiopathy in diabetes: an unsolved problem. Diabetes (1967) 0.75
Glucose tolerance, insulin and growth hormone in infants of gestational diabetic mothers. Pediatrics (1970) 0.75
Glomerulosclerosis in a strain of genetically diabetic mice. Diabetes (1968) 0.75
Quarter Century Victory Medal for Diabetes. A follow-up of patients one to 20 years later. Metabolism (1970) 0.75
Pre- and postnatal distribution of lipids in the liver of genetic diabetic mice. Experientia (1975) 0.75
Relationship of serum insulin to blood glucose: evidence of a defect during glucose tolerance in genetic prediabetic subjects. Vox Sang (1967) 0.75
[Role of metabolism regulation disorders in fatty tissue cells in the pathogenesis of diabetogenic effect of obesity in humans]. Pol Arch Med Wewn (1975) 0.75
Pharmacology of antihyperglycemic drugs. N Y State J Med (1972) 0.75
Renal glucose utilization in genetically diabetic microangiopathy. Experientia (1975) 0.75
Early stages of the diabetic state: definitions and concepts. Adv Metab Disord (1970) 0.75
[Evaluation of intestinal absorption by xylose test in diabetic enteropathy]. Pol Arch Med Wewn (1971) 0.75
Computation of the number of diabetics, as well as of diabetic genotypes and of the frequency of diabetic alleles in the Polish population above 14 years of age. Pol Med J (1971) 0.75
Vascular disease in diabetes and the effect of oral antidiabetic agents. Adv Metab Disord (1973) 0.75
Tolazamide in the treatment of diabetes mellitus: clinical experience and review of the literature. Curr Ther Res Clin Exp (1971) 0.75
Improved glucose disappearance following repeated glucose administration. Serum insulin growth hormone and free fatty acid levels during the Staub-Traugott effect. Diabetes (1969) 0.75
[Permissible physical effort criteria in juvenile diabetes]. Pol Arch Med Wewn (1974) 0.75
[Clinical aspects of the genetics of diabetes mellitus]. Ginekol Pol (1971) 0.75
[The use of methods applied in the study of cellular hormone receptors in clinical physiopathology]. Pol Arch Med Wewn (1975) 0.75